DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,723,718 | -1.7% | 6,948 | -4.9% | 0.07% | +15.9% |
Q2 2023 | $1,753,297 | -11.9% | 7,305 | -7.5% | 0.06% | -18.2% |
Q1 2023 | $1,990,891 | -8.6% | 7,899 | -3.8% | 0.08% | -15.4% |
Q4 2022 | $2,178,267 | -2.5% | 8,207 | -5.1% | 0.09% | -9.9% |
Q3 2022 | $2,233,000 | -2.4% | 8,648 | -4.2% | 0.10% | -1.9% |
Q2 2022 | $2,287,000 | -9.9% | 9,023 | +4.2% | 0.10% | +1.0% |
Q1 2022 | $2,539,000 | +154.4% | 8,659 | +185.5% | 0.10% | +100.0% |
Q4 2021 | $998,000 | -56.7% | 3,033 | -64.7% | 0.05% | -55.7% |
Q2 2021 | $2,304,561 | +104.1% | 8,588 | +71.2% | 0.12% | +76.9% |
Q1 2021 | $1,129,306 | +27.6% | 5,017 | +25.9% | 0.06% | +12.1% |
Q4 2020 | $885,260 | +3.5% | 3,985 | +0.3% | 0.06% | -15.9% |
Q3 2020 | $855,709 | +23.4% | 3,974 | +1.3% | 0.07% | +16.9% |
Q2 2020 | $693,651 | +35.6% | 3,923 | +6.1% | 0.06% | +5.4% |
Q1 2020 | $511,658 | +2.6% | 3,697 | +13.8% | 0.06% | +30.2% |
Q4 2019 | $498,813 | +6.7% | 3,250 | +0.4% | 0.04% | -4.4% |
Q3 2019 | $467,520 | +0.6% | 3,237 | -92.7% | 0.04% | +7.1% |
Q2 2019 | $464,833 | +0.5% | 44,270 | +1163.1% | 0.04% | -16.0% |
Q1 2019 | $462,730 | +28.9% | 3,505 | +0.7% | 0.05% | +6.4% |
Q4 2018 | $358,961 | -0.9% | 3,481 | +4.5% | 0.05% | +14.6% |
Q3 2018 | $362,055 | +28.9% | 3,332 | +17.1% | 0.04% | +13.9% |
Q2 2018 | $280,843 | +4.2% | 2,846 | +3.4% | 0.04% | -7.7% |
Q1 2018 | $269,546 | +6.5% | 2,753 | +0.9% | 0.04% | +8.3% |
Q4 2017 | $253,213 | +9.6% | 2,728 | +1.3% | 0.04% | -2.7% |
Q3 2017 | $231,091 | – | 2,694 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |